Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Receives Average Recommendation of Hold from Analysts

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) has earned a consensus recommendation of “Hold” from the three research firms that are presently covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation. The average 12-month price objective among brokerages that have updated their coverage on the stock in […]

Related Keywords

United States , ,Atara Biotherapeutics Inc ,Sg Americas Securities ,Redmile Group ,Nasdaq ,Advisor Group ,Vontobel Holding Ltd ,Josh Arnold Investment Consultant ,Get Free Report ,Marketbeat Ratings ,Arnold Investment Consultant ,Get Free ,Atara Biotherapeutics ,Nasdaq Atra ,Tatra ,Medical ,Ratings ,Consensus ,